ZX-RT20
$194.00
ZX-RT20 20mg. A research-grade synthetic triple incretin-receptor agonist peptide, supplied lyophilized for laboratory research. HPLC-verified to ≥99% purity, with identity confirmed by mass spectrometry on a per-lot basis. For research use only. Not for human use.
- ≥99% purity, HPLC-verified
- Identity confirmed by mass spectrometry
- Certificate of Analysis provided per lot
25 in stock
| Lot | Purity | Test Date | Lab | Status | COA |
|---|---|---|---|---|---|
| VP-260709-10 | 99.95% | 2026-07-13 | Freedom Diagnostics LLC | Passed | View PDF |
Be the first to review “ZX-RT20”
Specifications
| Purity | ≥99% |
|---|---|
| Appearance | White lyophilized powder |
| Solubility | Soluble in bacteriostatic water; reconstitute for laboratory research |
| Storage | Store lyophilized at -20°C, protected from light |
| Shelf Life | 24 months from date of manufacture (lyophilized) |
| Batch Number | VP-260709-10 |
Purity & Laboratory Testing
Each lot of ZX-RT20 20mg is analyzed by reversed-phase high-performance liquid chromatography (HPLC) and released at ≥99% purity. Peptide identity is confirmed by mass spectrometry (MS), verifying the molecular weight of the peptide against its expected value.
- Purity: HPLC, ≥99% (lot-specific value reported on the COA)
- Identity: confirmed by mass spectrometry (MS)
- Presentation: lyophilized powder, 20 mg nominal per vial
- Reference data: lot-specific values reported on the accompanying COA
A Certificate of Analysis (COA) accompanies each lot and reports the measured purity and identity values for that specific batch.
These analyses are analytical characterizations of identity and purity only and do not assess biological activity, safety, or fitness for any application. For research use only, not for human use.
Certificate of Analysis
A Certificate of Analysis is available per production lot, documenting HPLC purity and mass-spectrometry identity confirmation.
Research Background & Study Phase
For Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use.
References to clinical phases/studies describe the compound in independent third-party literature (e.g., ClinicalTrials.gov, PubMed) and do not represent claims, testing, or approval by Zynix Biolab.
Information about this compound's status in the scientific literature is provided for research context. Any references to research phases describe the compound as reported in independent, third-party studies and registries. They do not represent testing, evaluation, or approval by Zynix Biolab.
Research Applications
For Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use.
Supplied for in-vitro and laboratory research applications only. Not for human or veterinary use, and not for diagnostic or therapeutic use.
Handling & Storage
Storage — store lyophilized powder at -20°C, protected from light and moisture.
PPE — handle with appropriate personal protective equipment (gloves, lab coat, eye protection) under standard laboratory safety procedures.
For research use only — not for human use.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively for laboratory research; not a drug, food, cosmetic, or dietary supplement.
Reviews
There are no reviews yet.